FarmaKeio Custom Compounding expands into Conway
Pharmaceutical company FarmaKeio Custom Compounding announced Friday (Oct. 20) that it will open a new location at 1270 Dons Lane in Conway. The company will invest $2.29 million in the new facility, which the company projects will create 74 jobs.
“Today marks a momentous occasion for FarmaKeio as we proudly inaugurate our new Custom Compounding facility in Conway,” Dan DeNeui, CEO of FarmaKeio, said in a news release. “This state-of-the-art facility signifies our unwavering commitment to personalized patient care. We are excited about the possibilities this facility brings and are optimistic about its potential to further enhance our ability to positively impact patient lives.”
FarmaKeio is headquartered in Richardson, Texas. The new 16,000-square-foot Arkansas building will provide space for service and product lines. It will house research testing and development efforts.
US Compounding, a nationwide compounding pharmacy, was the Conway building’s most recent tenant.
“Congratulations to FarmaKeio on the acquisition of its newest facility in Arkansas, and congratulations to the team in Conway for securing this major investment,” Gov. Sarah Sanders said. “In my administration, we’re doing everything we can to make announcements like this regular by cutting taxes, investing in education, and building up a robust workforce.”
The company creates compounded hormone medications and peptide medications that support tailored integrative health treatment plans designed for individual patients. Hormone imbalances and specific medical conditions often require tailored medications to achieve optimal results.
“FarmaKeio Custom Compounding is a fast-growing company, and the State of Arkansas is proud to be the home for their next location,” said Clint O’Neal, executive director of the Arkansas Economic Development Commission. “Congratulations to the city of Conway, the Conway Development Corporation, and local stakeholders on this exciting new announcement.”
FarmaKeio Pharmacy hopes to develop the facility to include space for a second location for FarmaKeio Outsourcing. FarmaKeio Outsourcing is a 503B FDA-registered facility renowned for its patented pellet formulated with triamcinolone.
“As the fastest growing city in Arkansas, we welcome another fast-growing company to the city,” said Conway Mayor Bart Castleberry. “We thank FarmaKeio Custom Compounding for choosing Conway and for adding to the diverse array of job opportunities for our people.”